Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $731.0100 (-1.92%) ($731.0100 - $731.0100) on Thu. Oct. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.98% (three month average) | RSI | 56 | Latest Price | $731.0100(-1.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.1% a day on average for past five trading days. | Weekly Trend | REGN advances 2.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) DIA(38%) SPLV(36%) IWD(34%) SDY(33%) | Factors Impacting REGN price | REGN will decline at least -1.49% in a week (0% probabilities). TBT(-14%) UUP(-5%) VIXM(-4%) VXX(-1%) VCSH(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.49% (StdDev 2.98%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $728(0.41%) | 10 Day Moving Average | $712.8(2.55%) | 20 Day Moving Average | $708.53(3.17%) | To recent high | -1.9% | To recent low | 27.4% | Market Cap | $77.508b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |